Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Clinical implications of p53 mutations
R.R. Wallace-Brodeur; S.W. Lowe (Profiled Author: Scott Lowe)
Cellular and Molecular Life Sciences. 1999;55(1):64-75.
AbstractThe ultimate goal of basic cancer research is to provide a theoretical foundation for rational approaches to improve cancer therapy. Our extensive insight into the biology of the p53 tumour suppressor and the clinical behaviour of tumours harbouring p53 mutations indicates that information concerning p53 will be useful in diagnosis and prognosis, and may ultimately produce new therapeutic strategies. At the same time, efforts to understand the clinical implications of p53 mutations have revealed conceptual and technical limitations in translating basic biology to the clinic. The lessons learned from p53 may lay the groundwork for future efforts to synthesize cancer gene function, cancer genetics and cancer therapy.
PMID: 10065152
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
1993S.W. Lowe; H.E. Ruley; T. Jacks; D.E. Housman
p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents
Cell. 1993;74(6):957-967. -
2.
1999Clemens A. Schmitt; Mila E. McCurrach; Elisa De Stanchina; Rachel R. Wallace-Brodeur; Scott W. Lowe
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
Genes and Development. 1999;13(20):2670-2677. -
3.
2001M.A. Shah; G.K. Schwartz
Cell cycle-mediated drug resistance: An emerging concept in cancer therapy
Clinical Cancer Research. 2001;7(8):2168-2181.
Related Topics
Appears in this Document
Related Experts
Author of this Document
-
Internal ExpertsPublications
-
197









-
170









-
190









-
203









-
343









-
436











